Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Regenerx Biopharmaceuticals Inc (RGN) since 2018 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Regenerx Biopharmaceuticals Inc. Table 2 shows the detailed insider transactions. This company's CIK number is 707511.
Total stock buying since 2018: $4,164,744.
Total stock sales since 2018: $2,664,502.
Total stock option exercises since 2018: $0.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2021 | 200,000 | $40,000 | 0 | $0 | 0 | $0 |
| 2018 | 17,933,673 | $4,124,744 | 11,584,795 | $2,664,502 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2021-06 | 200,000 | $40,000 | 0 | $0 | 0 | $0 |
| 2018-03 | 17,933,673 | $4,124,744 | 11,584,795 | $2,664,502 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2021-06-30 | Finkelstein J J (President and CEO) | Buy | 75,000 | .20 | 15,000 |
| 2021-06-30 | Goldstein Allan L | Buy | 125,000 | .20 | 25,000 |
| 2018-03-13 | Cavazza Preta Martina | Buy | 17,933,673 | .23 | 4,124,744 |
| 2018-03-13 | Sinaf S.a. | Sale | 11,584,795 | .23 | 2,664,502 |
Insider trading activities including stock purchases, stock sales, and option exercises of RGN listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Regenerx Biopharmaceuticals Inc (symbol RGN, CIK number 707511) see the Securities and Exchange Commission (SEC) website.